1000minds is used for prioritizing diseases for Research and Development.
Globally, there is an urgent need for new antibiotics to treat diseases that are becoming increasingly resistant to antibiotics. Millions of people are likely to die if new and effective antibiotics are not developed.
In 2016, Member States mandated the World Health Organization (WHO) to create a Priority Pathogens List (PPL) of antibiotic-resistant bacteria posing the greatest threats to human health. The main goal of the PPL is to guide R&D into new antibiotics by pharmaceutical companies, universities and public research institutions.
1000minds was used to survey and aggregate the preferences of experts in infectious diseases from around the world.
The European Centre for Disease Prevention and Control (ECDC) also used 1000minds to prioritize infectious disease threats.
Peer-reviewed publications
About the use of 1000minds for prioritizing diseases for R&D.